Successful Therapy of Severe and Refractory Cutaneous Sarcoidosis with Baricitinib
DOI:
https://doi.org/10.2340/actadv.v104.39970Keywords:
sarcoidosis, JAK inhibitors, baricitinibAbstract
Abstract is missing (Short communication)
Downloads
References
Karadağ AS, Parish LC. Sarcoidosis: a great imitator. Clin Dermatol 2019; 37: 240-254.
https://doi.org/10.1016/j.clindermatol.2019.01.005 DOI: https://doi.org/10.1016/j.clindermatol.2019.01.005
Bergeron A, Bonay M, Kambouchner M, Lecossier D,
Riquet M, Soler P, et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 1997; 159: 3034-3043.
https://doi.org/10.4049/jimmunol.159.6.3034 DOI: https://doi.org/10.4049/jimmunol.159.6.3034
Toriola SL, Satnarine T, Zohara Z, Adelekun A, Seffah KD, Salib K, et al. Recent clinical studies on the effects of tumor necrosis factor-alpha (TNF-α) and Janus kinase/signal transducers and activators of transcription (JAK/STAT) antibody therapies in refractory cutaneous sarcoidosis: a systematic review. Cureus 2023; 15: e44901.
https://doi.org/10.7759/cureus.44901 DOI: https://doi.org/10.7759/cureus.44901
Zhou T, Casanova N, Pouladi N, Wang T, Lussier Y, Knox KS, et al. Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature. Sci Rep 2017; 7: 4237.
https://doi.org/10.1038/s41598-017-04109-6 DOI: https://doi.org/10.1038/s41598-017-04109-6
Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156: 4952-4960.
https://doi.org/10.4049/jimmunol.156.12.4952 DOI: https://doi.org/10.4049/jimmunol.156.12.4952
Reich K, Kabashima K, Peris K, Silverberg JI, Eichenfield LF, Bieber T, et al. Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol 2020; 156: 1333-1343.
https://doi.org/10.1001/jamadermatol.2020.3260 DOI: https://doi.org/10.1001/jamadermatol.2020.3260
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Giuseppe Russo, Emmanuel Laffitte
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
